Enrolling by invitationPhase 2NCT06826326

Neuroimaging of Escitalopram in Autism Spectrum Disorder

Studying Interatrial communication

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kathryn Unruh
Principal Investigator
Kathryn E Unruh, PhD
University of Kansas
Intervention
Escitalopram 10mg(drug)
Enrollment
5 target
Eligibility
12-17 years · All sexes
Timeline
2025 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06826326 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication →

← Back to all trials